Clinical Trial Update: Maintenance Treatment of Apatinib in Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update on maintenance treatment with apatinib for nasopharyngeal carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Guilin Medical University, China | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: UNKNOWN